CausalSentinel

Protein Dossier — TNFRSF11A (Tumor necrosis factor receptor superfamily member 11A)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Paget’s disease 2.15 0.297 4.72e-13 Wald ratio 1 cis 0.99
Heel bone mineral density (BMD) T-score automated -0.111 0.0161 6.61e-12 Wald ratio 1 cis 1
Lumbar spine bone mineral density -0.278 0.0457 1.12e-09 Wald ratio 1 cis NA
Femoral neck bone mineral density -0.189 0.0394 1.60e-06 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoporosis 0.27 0.0767 4.31e-04 Wald ratio 1 cis NA
Fractured bone site(s): Wrist 0.229 0.071 0.00127 Wald ratio 1 cis NA
Diagnoses - main ICD10: M17 Gonarthrosis [arthrosis of knee] -0.472 0.148 0.00138 Wald ratio 1 cis NA
Body mass index (BMI) -0.0362 0.0124 0.00361 Wald ratio 1 cis NA
Non-cancer illness code self-reported: vaginal prolapse or uterine prolapse 0.349 0.121 0.00393 Wald ratio 1 cis NA
Forced vital capacity (FVC) 0.0279 0.0102 0.00621 Wald ratio 1 cis NA
Diagnoses - main ICD10: M16 Coxarthrosis [arthrosis of hip] -0.375 0.155 0.0158 Wald ratio 1 cis NA
Fasting insulin -0.0371 0.0161 0.0211 Wald ratio 1 cis NA
…and 104 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5424_55_3 RANK Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

120 association rows across 71 traits (109 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
TNFRSF11A/TNFRSF1A protein level ratio 1e-1835 rs74938001 1 GCST90315928 no MR -> candidate analysis
Circulating TNFRSF11A levels 2e-1622 rs62098352 3 GCST90859756 no MR -> candidate analysis
TNFRSF11A/TNFRSF1B protein level ratio 2e-1447 rs74938001 1 GCST90315929 no MR -> candidate analysis
Tumor necrosis factor receptor superfamily member 11A levels 9e-101 rs80067526 3 GCST90179450 no MR -> candidate analysis
Cerebrospinal fluid protein TNFRSF11A levels 2e-79 rs35211496 1 GCST90943993 no MR -> candidate analysis
Alkaline phosphatase (UKB data field 30610) 3e-73 rs884205 1 GCST90468060 no MR -> candidate analysis
Serum alkaline phosphatase levels 3e-65 rs884205 7 GCST90018942 no MR -> candidate analysis
TNFRSF11A protein levels 9e-47 rs141434942 10 GCST90470902 no MR -> candidate analysis
Heel bone mineral density 6e-38 rs884205 7 GCST006979 MR: beta=-0.111, p=6.61e-12 (cis)
Estimated bone mineral density 3e-35 rs884205 2 GCST90726625 no MR -> candidate analysis
Height 5e-28 rs884205 2 GCST90245848 MR: beta=0.0183, p=0.228 (cis)
Circulating COL1A1 levels 4e-27 rs2957126 1 GCST90859986 no MR -> candidate analysis
…and 59 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1431 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Osteopetrosis - hypogammaglobulinemia 0.847 established (curated) no MR -> candidate analysis
autosomal recessive osteopetrosis 7 0.829 established (curated) no MR -> candidate analysis
familial expansile osteolysis 0.738 established (curated) no MR -> candidate analysis
bone Paget disease 0.531 established (curated) no MR -> candidate analysis
osteoporosis 0.839 common-variant locus MR: beta=0.27, p=4.31e-04 (cis)
bone disorder 0.582 established (curated) MR: beta=0.177, p=0.458 (cis)
asthma 0.69 common-variant locus no MR -> candidate analysis
hypothyroidism 0.715 common-variant locus MR: beta=-0.143, p=0.0261 (cis)
allergic rhinitis 0.696 common-variant locus MR: beta=-0.0945, p=0.0941 (cis)
Eczematoid dermatitis 0.664 common-variant locus no MR -> candidate analysis
childhood onset asthma 0.656 common-variant locus no MR -> candidate analysis
myasthenia gravis 0.629 common-variant locus no MR -> candidate analysis
dysosteosclerosis 0.608 established (curated) no MR -> candidate analysis
osteoarthritis, hip 0.609 common-variant locus MR: beta=-0.183, p=0.0864 (cis)
myxedema 0.604 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 10 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Tumor necrosis factor ligand superfamily member 11/11A)
gnomAD constraint pLI=5.4e-06, LOEUF=0.772 — LoF-tolerant
GWAS Catalog 73 unique SNPs / 146 rows
ClinVar 891 records; 5 pathogenic in sample of 30
PharmGKB/ClinPGx 2 clinical annotations across 6 drugs

Caveats declared by the tools

Sources

Provenance